About Index Trending news
Lists
Pricing
Sanderling Ventures

Sanderling Ventures

Sanderling Ventures

Sanderling has supported over 90 biomedical companies earning consistently high rates of return on its venture investments.

Elsewhere

Alexa global traffic share

Investment profile

Geographical Focus
United States
Markets focus
Health Care Biotechnology
Stage Focus

Activity

Past year's investments

Sanderling Ventures participated in fewer than 3 rounds over the past year

Latest rounds
  • PreciThera, Inc.: Venture capital (Series A) ($36M)
  • PreciThera, Inc.: Venture capital (Series A) ($36M)
  • Glycomine Inc.: Venture capital (Series A) ($12M)
Total funding
$217.2M in 5 rounds from 14 investors
By Sanderling Ventures
$23.1M Series D in Feb, 2007
Total funding
$64M in 4 rounds from 13 investors
By Sanderling Ventures
$12.2M Series D in Dec, 2011
Total funding
$30.3M in 3 rounds from 16 investors
By Sanderling Ventures
$3.5M Series C in Dec, 2013
Total funding
$8M in 4 rounds from 7 investors
By Sanderling Ventures
$4M Venture capital in Jun, 2008
Total funding
$65M in 3 rounds from 15 investors
By Sanderling Ventures
$25M Series E in Jul, 2016
Exit Ethicon, Mar 27, 2017
Total funding
$56M in 3 rounds from 3 investors
By Sanderling Ventures
$21M Series D in Oct, 2010
Total funding
$44M in 1 rounds from 8 investors
By Sanderling Ventures
$44M Series C in Jan, 2007
Total funding
$100M in 1 rounds from 5 investors
By Sanderling Ventures
$100M Series B in Apr, 2016
Total funding
$12M in 1 rounds from 2 investors
By Sanderling Ventures
$12M Series A in Nov, 2016
Total funding
$72M in 2 rounds from 10 investors
By Sanderling Ventures
$36M Series A in Jul, 2017

Want to see the complete list?
Go Pro!